{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:19:34Z","timestamp":1793146774753,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedhc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Health Care"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pedhc.2024.07.013","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:33:14Z","timestamp":1727083994000},"page":"289-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Methamphetamine and Ecstasy-Induced Acute Reversible Cerebellar Neurotoxicity in a 3-Year-Old Child: A Case Report"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-4745","authenticated-orcid":false,"given":"Mustafa Tolga","family":"Tunagur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Merve","family":"Kurt Tunagur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedhc.2024.07.013_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108518","article-title":"Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism","volume":"188","author":"Amaro","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0002","series-title":"Psychology of substance abuse: Psychotherapy, clinical management and social intervention","first-page":"3","article-title":"Psychopharmacology of drugs of abuse","author":"Boos","year":"2021"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0003","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/ene.15729","article-title":"Acute truncal ataxia without nystagmus in patients with acute vertigo","volume":"30","author":"Carmona","year":"2023","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0004","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1021\/acschemneuro.8b00155","article-title":"Dark classics in chemical neuroscience: 3,4-methylenedioxymethamphetamine","volume":"9","author":"Dunlap","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0005","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. (2019). Turkey Country Drug Report 2019. European Union Drugs Agency."},{"key":"10.1016\/j.pedhc.2024.07.013_bib0006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2013.07.014","article-title":"Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine","volume":"97","author":"Halpin","year":"2014","journal-title":"Life Sciences"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31031\/AICS.2022.03.000564","article-title":"Toxic encephalopathy following methamphetamine, MDMA, and marijuana intoxication: A case report","volume":"3","author":"Howell","year":"2022","journal-title":"Advancements in Case Studies"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113795","article-title":"Neurotoxicity of methamphetamine: Main effects and mechanisms","volume":"344","author":"Jayanthi","year":"2021","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40360-016-0068-7","article-title":"Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: A case series","volume":"17","author":"Liakoni","year":"2016","journal-title":"BMC Pharmacology and Toxicology"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0010","series-title":"Substance use. Child and adolescent behavioral health: A resource for advanced practice psychiatric and primary care practitioners in nursing","first-page":"397","author":"McKinnon","year":"2021"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0011","first-page":"16","article-title":"Neurobiology and clinical manifestations of methamphetamine neurotoxicity","volume":"33","author":"Moszczynska","year":"2016","journal-title":"The Psychiatric Times"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0012","first-page":"381","article-title":"MDMA and the brain: A short review on the role of neurotransmitters in neurotoxicity","volume":"11","author":"Mustafa","year":"2020","journal-title":"Basic and Clinical Neuroscience"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0013","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/HMR.0000000000000229","article-title":"Organizational facilitators and barriers to optimal APRN practice: An integrative review","volume":"45","author":"Schirle","year":"2020","journal-title":"Health Care Management Review"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0014","doi-asserted-by":"crossref","unstructured":"United Nations Office on Drugs and Crime. (2023). World Drug Report 2023. United Nations publication.","DOI":"10.18356\/9789210028233"},{"key":"10.1016\/j.pedhc.2024.07.013_bib0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fnmol.2018.00186","article-title":"The main molecular mechanisms underlying methamphetamine-induced neurotoxicity and implications for pharmacological treatment","volume":"11","author":"Yang","year":"2018","journal-title":"Frontiers in Molecular Neuroscience"}],"container-title":["Journal of Pediatric Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524524001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524524001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T16:16:33Z","timestamp":1760199393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891524524001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0891524524001871"],"URL":"https:\/\/doi.org\/10.1016\/j.pedhc.2024.07.013","relation":{},"ISSN":["0891-5245"],"issn-type":[{"value":"0891-5245","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methamphetamine and Ecstasy-Induced Acute Reversible Cerebellar Neurotoxicity in a 3-Year-Old Child: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Health Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedhc.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}